ARTICLE | Distillery Techniques
Imaging
June 6, 2018 7:04 PM UTC
An OX40-targeting PET imaging agent could help predict responses to immunotherapy in cancer. The agent consisted of a 64Cu radionuclide-labeled mouse mAb targeting OX40, a marker of T cell activation....
BCIQ Company Profiles